These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 4743550)

  • 41. A transmissible feline fibrosarcoma of viral origin.
    McDonough SK; Larsen S; Brodey RS; Stock ND; Hardy WD
    Cancer Res; 1971 Jul; 31(7):953-6. PubMed ID: 4997847
    [No Abstract]   [Full Text] [Related]  

  • 42. Morphological studies on transmissible feline fibrosarcoma.
    Snyder SP; Theilen GH; Richards WP
    Cancer Res; 1970 Jun; 30(6):1658-67. PubMed ID: 4989777
    [No Abstract]   [Full Text] [Related]  

  • 43. Tumor-induced skin heterogenization. II. Virus causing the phenomenon.
    Svet-Moldavsky GJ; Liozner AL; Mkheidze DM; Sokolov PP; Bykovsky AP
    J Natl Cancer Inst; 1970 Sep; 45(3):475-84. PubMed ID: 4943064
    [No Abstract]   [Full Text] [Related]  

  • 44. Antibodies in normal and leukemic cats to feline oncornavirus-associated cell membrane antigens.
    Jarrett W; Essex M; Mackey L; Jarrett O; Laird H
    J Natl Cancer Inst; 1973 Jul; 51(1):261-3. PubMed ID: 4578581
    [No Abstract]   [Full Text] [Related]  

  • 45. Lysis of feline lymphoma cells by complement-dependent antibodies in feline leukemia virus contact cats. Correlation of lysis and antibodies to feline oncornavirus-associated cell membrane antigen.
    Grant CK; Essex M; Pedersen NC; Hardy WD; Stephenson JR; Cotter SM; Theilen GH
    J Natl Cancer Inst; 1978 Jan; 60(1):161-6. PubMed ID: 203702
    [No Abstract]   [Full Text] [Related]  

  • 46. Cellular and viral antigens of BALB-c myeloma.
    Krueger RG; Williams WH; Miller GC
    J Natl Cancer Inst; 1974 Apr; 52(4):1203-10. PubMed ID: 4133200
    [No Abstract]   [Full Text] [Related]  

  • 47. Protection of cats against progressive fibrosarcomas and persistent leukemia virus infection by vaccination with feline leukemia cells.
    Grant CK; de Noronha F; Tusch C; Michalek MT; McLane MF
    J Natl Cancer Inst; 1980 Dec; 65(6):1285-92. PubMed ID: 6253714
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Immunological surveillance in neoplasia.
    Burnet FM
    Transplant Rev; 1971; 7():3-25. PubMed ID: 5146537
    [No Abstract]   [Full Text] [Related]  

  • 49. Tumor-induced skin heterogenization. 3. Immunologic and immunogenetic mechanisms.
    Liozner AL; Svet-Moldavsky GJ; Mkheidze DM
    J Natl Cancer Inst; 1970 Sep; 45(3):485-94. PubMed ID: 4943065
    [No Abstract]   [Full Text] [Related]  

  • 50. [Immunochemical studies on tumors].
    Grabar P
    Arq Patol; 1969 Aug; 41(2):239-50. PubMed ID: 5403873
    [No Abstract]   [Full Text] [Related]  

  • 51. [Feline leukemogenic and sarcomatogenic viruses].
    Parodi AL
    C R Seances Soc Biol Fil; 1975; 169(3 Suppl):794-806. PubMed ID: 175893
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Demonstration of antibody in cat sera to feline oncornavirus by complement-fixation inhibition.
    Olsen RG; Yohn DS
    J Natl Cancer Inst; 1972 Aug; 49(2):395-403. PubMed ID: 4343689
    [No Abstract]   [Full Text] [Related]  

  • 53. Evidence for a human osteosarcoma virus.
    Pritchard DJ; Reilly CA; Finkel MP
    Nat New Biol; 1971 Nov; 234(47):126-7. PubMed ID: 4943520
    [No Abstract]   [Full Text] [Related]  

  • 54. Preparation of membrane fractions with enhanced tumor-transplantation-antigen activity from tumor cells infected with influenza virus.
    Boone CW; Orme TW; Blackman K; Gillette R
    J Natl Cancer Inst; 1973 Oct; 51(4):1141-4. PubMed ID: 4355600
    [No Abstract]   [Full Text] [Related]  

  • 55. Pseudotypes of feline sarcoma virus contain an 85,000-dalton protein with feline oncornavirus-associated cell membrane antigen (FOCMA) activity.
    Sherr CJ; Sen A; Todaro GJ; Sliski A; Essex M
    Proc Natl Acad Sci U S A; 1978 Mar; 75(3):1505-9. PubMed ID: 206902
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Feline sarcoma virus tumor induction in cats and dogs.
    Gardner MB; Arnstein P; Johnson E; Rongey RW; Charman HP; Huebner RJ
    J Am Vet Med Assoc; 1971 Mar; 158(6):Suppl 2:1046+. PubMed ID: 5103501
    [No Abstract]   [Full Text] [Related]  

  • 57. Serological studies of normal and leukemic cats in a multiple-case leukemia cluster.
    Cotter SM; Essex M; Hardy WD
    Cancer Res; 1974 May; 34(5):1061-9. PubMed ID: 4366982
    [No Abstract]   [Full Text] [Related]  

  • 58. Immunogenic properties of a soluble tumor-specific transplantation antigen induced by Simian virus 40.
    Drapkin MS; Appella E; Law LW
    J Natl Cancer Inst; 1974 Jan; 52(1):259-64. PubMed ID: 4129833
    [No Abstract]   [Full Text] [Related]  

  • 59. Circulating levels of feline leukemia and sarcoma viruses and fibrosarcoma regression in persistently viremic cats.
    de Noronha F; Grant CK; Lutz H; Keyes A; Rowston W
    Cancer Res; 1983 Apr; 43(4):1663-8. PubMed ID: 6299527
    [No Abstract]   [Full Text] [Related]  

  • 60. Factors interfering with immunological rejection of tumours.
    Baldwin RW; Robins RA
    Br Med Bull; 1976 May; 32(2):118-23. PubMed ID: 782631
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.